SCHEMBL19136733

SCHEMBL19136733

O=c1c(O)c(-c2cc(O)c(O)cc2O)oc2cc(O)ccc12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.73
▸ MEN1 O00255 7/20 0.73
▸ KDM4E B2RXH2 7/20 0.73
▸ CYP3A4 P08684 7/20 0.73
▸ MAPT P10636 6/20 0.73
▸ HSD17B10 Q99714 6/20 0.73
▸ ALDH1A1 P00352 6/20 0.73
▸ CASP1 P29466 5/20 0.73
▸ CASP7 P55210 5/20 0.73
▸ CYP2C9 P11712 5/20 0.73
▸ TP53 P04637 4/20 0.73
▸ HPGD P15428 4/20 0.73
▸ ALOX15 P16050 4/20 0.73
▸ MAPK1 P28482 3/20 0.73
▸ RECQL P46063 3/20 0.73
▸ CDK5 Q00535 2/20 0.73
▸ CDK5R1 Q15078 2/20 0.73
▸ LMNA P02545 2/20 0.73
▸ APP P05067 2/20 0.73
▸ CSNK2A2 P19784 2/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fisetin SCHEMBL29349742 0.84 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Fisetin SCHEMBL29381611 0.84 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Fisetin SCHEMBL29394036 0.84 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Fisetin SCHEMBL116861 0.84 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Fisetin SCHEMBL39454 0.84 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Robinetin SCHEMBL217743 0.84 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Robinetin SCHEMBL29883566 0.84 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Resokaempferol SCHEMBL30873045 0.83 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Resokaempferol SCHEMBL344710 0.83 MEN1 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT
Fisetin SCHEMBL4263659 0.83 CDK5 (1.00) KMT2AMEN1KDM4ECYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624182-B2 Functionalized cellular elastomer foam, and a use of a cellular elastomer foam as a catalyst substrate UNIVERSITE DE STRASBOURG (FR) 2026-05-12 — — US claimed
US-20220145038-A1 FUNCTONALIZED CELLULAR ELASTOMER FOAM, AND A USE OF A CELLULAR ELASTOMER FOAM AS A CATALYST SUBSTRATE-- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-05-12 — — US claimed
US-12624182-B2 Functionalized cellular elastomer foam, and a use of a cellular elastomer foam as a catalyst substrate UNIVERSITE DE STRASBOURG (FR) 2026-05-12 — — US disclosed
US-20220145038-A1 FUNCTONALIZED CELLULAR ELASTOMER FOAM, AND A USE OF A CELLULAR ELASTOMER FOAM AS A CATALYST SUBSTRATE-- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-05-12 — — US disclosed
US-11267947-B2 Method for modifying the surface properties of elastomer cellular foams UNIVERSITE DE STRASBOURG (FR) 2022-03-08 — — US disclosed
US-20170210872-A1 METHOD FOR MODIFYING THE SURFACE PROPERTIES OF ELASTOMER CELLULAR FOAMS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624182-B2 Functionalized cellular elastomer foam, and a use of a cellular elastomer foam as a catalyst substrate PNMT, COMT, SMCHD1 KMT2A 1522/4885MEN1 4038/4885KDM4E 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback